A 26-year-old, gravida 3, para 2 Jehovah’s Witness with a complete placenta previa presents at 36 weeks’ gestation with uterine contractions and moderate vaginal bleeding. A cesarean delivery is planned. Based on a recent retrospective study that explored views about blood product administration among antenatal Jehovah’s Witness patients, which of the following would she most likely accept?

Peripartum hemorrhage is a significant factor in maternal morbidity and mortality throughout the world, as well as within the United States. Anesthesiologists and other health care providers are aware that most Jehovah’s Witnesses will not accept a blood product transfusion, as it is a violation of their religious beliefs. However, the decision to receive recombinant, fractionated or salvaged blood products is often left to individual discretion.

The authors of a recent study retrospectively examined the transfusion preferences of 87 antenatal Jehovah’s Witness...

You do not currently have access to this content.